1.1 is Blackrock Health Sciences Trust’s (NYSE:BME) Institutional Investor Sentiment

April 23, 2018 - By Winifred Garcia

Sentiment for Blackrock Health Sciences Trust (NYSE:BME)

Blackrock Health Sciences Trust (NYSE:BME) institutional sentiment decreased to 1.1 in Q4 2017. Its down -0.53, from 1.63 in 2017Q3. The ratio is negative, as 11 active investment managers opened new or increased positions, while 10 decreased and sold holdings in Blackrock Health Sciences Trust. The active investment managers in our partner’s database now hold: 1.20 million shares, down from 1.21 million shares in 2017Q3. Also, the number of active investment managers holding Blackrock Health Sciences Trust in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 8 Increased: 7 New Position: 4.

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The company has market cap of $301.69 million. The fund is managed by BlackRock Advisors, LLC. It has a 8.1 P/E ratio. It invests in the public equity markets of the United States.

The stock decreased 0.10% or $0.035 during the last trading session, reaching $34.885. About 1,859 shares traded. BlackRock Health Sciences Trust (NYSE:BME) has risen 0.88% since April 23, 2017 and is uptrending. It has underperformed by 10.67% the S&P500.

Arete Wealth Advisors Llc holds 0.1% of its portfolio in BlackRock Health Sciences Trust for 8,586 shares. First Allied Advisory Services Inc. owns 33,503 shares or 0.05% of their US portfolio. Moreover, Cordasco Financial Network has 0.03% invested in the company for 750 shares. The Indiana-based 1St Source Bank has invested 0.02% in the stock. Clenar Muke Llc, a California-based fund reported 13,527 shares.

BlackRock Health Sciences Trust (NYSE:BME) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.